J CROW: Open Payments
NPI 1972383552 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$211 in 11 payments from 7 companies in 2025. Trend: 2023 $20 · 2024 $456 · 2025 $211
Food & beverage: $211
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Amgen Inc. | 2 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $22 |
| ABBVIE INC. | 1 | $19 |
Products named: JARDIANCE, AIRSUPRA, TRELEGY ELLIPTA, Kerendia, UBRELVY, SHINGRIX, REPATHA, OTEZLA.
Industry payments across TX — which companies pay providers there.
